Association Between Loop Diuretic Dose Changes and Outcomes in Chronic Heart Failure: Observations from the ESC-EORP Heart Failure Long-Term Registry
Chris J. Kapelios(Laiko General Hospital of Athens), Frank Ruschitzka(Kantonsspital St. Gallen), Gerasimos Filippatos(National and Kapodistrian University of Athens), Theresa A. McDonagh, Andrew J.S. Coats(The Heart Research Institute), Marco Metra(Vita-Salute San Raffaele University), Mitja Lainščak, Lars H. Lund(Karolinska University Hospital), Giuseppe Rosano(St George's Hospital), Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Massimo Piepoli(University of Milan), Wilfried Müllens(Ziekenhuis Oost-Limburg), Aldo P. Maggioni(Health Care Foundation), Brenda Moura(Universidade do Porto), Cécile Laroche(European Society of Cardiology), Maria G. Crespo‐Leiro(University of Cyprus), Stefan D. Anker(Bayer (Germany)), Beatria Díaz‐Molina(Hospital Universitario Central de Asturias)
Cited by 66
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k